Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Oct;42(4):495–502. doi: 10.1038/bjc.1980.271

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces.

T J Hamblin, A K Abdul-Ahad, J Gordon, F K Stevenson, G T Stevenson
PMCID: PMC2010447  PMID: 7192154

Abstract

Tumour-specific antiserum was raised in sheep against idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes from a patient with chronic lymphocytic leukaemia (prolymphocytic variant). The complement-activating IgG1 subclass of the anti-idiotype was prepared from the serum in monodisperse form for infusion. Two treatments of 480 and 1200 mg caused the white-cell count to fall by one-third and one-half respectively. However, there was a rapid resurgence, so that by 8 days after each treatment the counts were restored to approximately 85% of their former levels. No change was noted in the size of spleen or lymph nodes. Each treatment probably destroyed 4-8 X 10(11) cells, some 10% of the total tumour load. The antibody was rapidly consumed, and there was evidence of heavy utilization of complement.

Full text

PDF
498

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERLIN R. D., WOOD W. B., Jr STUDIES ON THE PATHOGENESIS OF FEVER. 13. THE EFFECT OF PHAGOCYTOSIS ON THE RELEASE OF ENDOGENOUS PYROGEN BY POLYMORPHONUCLEAR LEUKOCYTES. J Exp Med. 1964 May 1;119:715–726. doi: 10.1084/jem.119.5.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernstein I. D., Tam M. R., Nowinski R. C. Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. Science. 1980 Jan 4;207(4426):68–71. doi: 10.1126/science.6965328. [DOI] [PubMed] [Google Scholar]
  3. Capra J. D., Kehoe J. M. Hypervariable regions, idiotypy, and the antibody-combining site. Adv Immunol. 1975;20:1–40. doi: 10.1016/s0065-2776(08)60205-9. [DOI] [PubMed] [Google Scholar]
  4. DRESSER D. W. Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology. 1962 May;5:378–388. [PMC free article] [PubMed] [Google Scholar]
  5. Eady R. P., Hough D. W., Kilshaw P. J., Stevenson G. T. Recovery of immunoglobulin removed from lymphocytic surfaces by proteolysis. Immunology. 1974 Mar;26(3):549–561. [PMC free article] [PubMed] [Google Scholar]
  6. Fakhri O., McLaughlin H., Hobbs J. R. 7S anti-tumour antibodies and activated Fc in macrophage tumour cell interaction. Eur J Cancer. 1973 Jan;9(1):19–23. doi: 10.1016/0014-2964(73)90038-8. [DOI] [PubMed] [Google Scholar]
  7. Fine D. P., Marney S. R., Jr, Colley D. G., Sergent J. S., Des Prez R. M. C3 shunt activation in human serum chelated with EGTA. J Immunol. 1972 Oct;109(4):807–809. [PubMed] [Google Scholar]
  8. Galton D. A., Goldman J. M., Wiltshaw E., Catovsky D., Henry K., Goldenberg G. J. Prolymphocytic leukaemia. Br J Haematol. 1974 May;27(1):7–23. doi: 10.1111/j.1365-2141.1974.tb06769.x. [DOI] [PubMed] [Google Scholar]
  9. Grant C. K., Adams E., Miller H. R. Leukocyte-dependent antibody in sheep immunized with murine mastocytoma cells. Eur J Immunol. 1975 May;5(5):324–330. doi: 10.1002/eji.1830050507. [DOI] [PubMed] [Google Scholar]
  10. Grey H. M., Rabellino E., Pirofsky B. Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest. 1971 Nov;50(11):2368–2375. doi: 10.1172/JCI106735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Haughton G., Lanier L. L., Babcock G. F., Lynes M. A. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen. J Immunol. 1978 Dec;121(6):2358–2362. [PubMed] [Google Scholar]
  12. Hough D. W., Eady R. P., Hamblin T. J., Stevenson F. K., Stevenson G. T. Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes. J Exp Med. 1976 Oct 1;144(4):960–969. doi: 10.1084/jem.144.4.960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hugli T. E., Müller-Eberhard H. J. Anaphylatoxins: C3a and C5a. Adv Immunol. 1978;26:1–53. doi: 10.1016/s0065-2776(08)60228-x. [DOI] [PubMed] [Google Scholar]
  14. Johansson B., Klein E., Haglund S. Correlation between the presence of surface localized immunoglobulin (Ig) and the histological type of human malignant lymphomas. Clin Immunol Immunopathol. 1976 Jan;5(1):119–132. doi: 10.1016/0090-1229(76)90155-0. [DOI] [PubMed] [Google Scholar]
  15. Kassel R. L., Old L. J., Carswell E. A., Fiore N. C., Hardy W. D., Jr Serum-mediated leukemia cell destruction in AKR mice. J Exp Med. 1973 Oct 1;138(4):925–938. doi: 10.1084/jem.138.4.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leech J. H., Glick A. D., Waldron J. A., Flexner J. M., Horn R. G., Collins R. D. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies. J Natl Cancer Inst. 1975 Jan;54(1):11–21. doi: 10.1093/jnci/54.1.11. [DOI] [PubMed] [Google Scholar]
  17. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  18. Manaster J., Frühling J., Stryckmans P. Kinetics of lymphocytes in chronic lymphocytic leukemia. I. Equilibrium between blood and a "readily accessible pool". Blood. 1973 Mar;41(3):425–438. [PubMed] [Google Scholar]
  19. Porath J., Axen R., Ernback S. Chemical coupling of proteins to agarose. Nature. 1967 Sep 30;215(5109):1491–1492. doi: 10.1038/2151491a0. [DOI] [PubMed] [Google Scholar]
  20. Proctor J. W., Rudenstam C. M., Alexander P. A factor preventing the development of lung metastases in rats with sarcomas. Nature. 1973 Mar 2;242(5392):29–31. doi: 10.1038/242029a0. [DOI] [PubMed] [Google Scholar]
  21. Scott J. L., McMillan R., Marino J. V., Davidson J. G. Leukocyte labeling with 51 chromium. IV. The kinetics of chronic lymphocytic leukemic lymphocytes. Blood. 1973 Jan;41(1):155–162. [PubMed] [Google Scholar]
  22. Stevenson F. K., Elliott E. V. Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants. Immunology. 1978 Feb;34(2):353–358. [PMC free article] [PubMed] [Google Scholar]
  23. Stevenson F. K., Elliott E. V., Stevenson G. T. Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin. Immunology. 1977 Apr;32(4):549–557. [PMC free article] [PubMed] [Google Scholar]
  24. Stevenson F. K., Elliott E. V., Stevenson G. T. Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin. Immunology. 1977 Apr;32(4):549–557. [PMC free article] [PubMed] [Google Scholar]
  25. Stevenson G. T., Elliott E. V., Stevenson F. K. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc. 1977 Aug;36(9):2268–2271. [PubMed] [Google Scholar]
  26. Stevenson G. T., Stevenson F. K. Antibody to a molecularly-defined antigen confined to a tumour cell surface. Nature. 1975 Apr 24;254(5502):714–716. doi: 10.1038/254714a0. [DOI] [PubMed] [Google Scholar]
  27. Strong R., Watkins J. A simple electrophoretic technique for the estimation of complement C3 conversion: specific application to the investigation of anaphylactoid response to I.V. agents. J Immunol Methods. 1979;29(3):293–297. doi: 10.1016/0022-1759(79)90318-1. [DOI] [PubMed] [Google Scholar]
  28. Themi H., Trepel F., Schick P., Kaboth W., Begemann H. Kinetics of lymphocytes in chronic lymphocytic leukemia: studies using continuous 3H-thymidine infusion in two patients. Blood. 1973 Oct;42(4):623–636. [PubMed] [Google Scholar]
  29. Virji M., Stevenson G. T. Antibody-induced changes in levels of cyclic adenosine monophosphate in leukaemic lymphocytes. Br J Cancer. 1979 Apr;39(4):434–440. doi: 10.1038/bjc.1979.77. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES